Oncolytic Viruses: A New Class of Immunotherapy Drugs against Cancer Reporter: Aviva Lev-Ari, PhD, RN             Oncolytic viruses represent a new class of therapeutic agents that promote anti-tumour responses through a dual mechanism of action that is dependent on selective tumour cell killing and the induction of systemic anti-tumour immunity. … Continue reading Oncolytic Viruses: A New Class of Immunotherapy Drugs against Cancer